Literature DB >> 2140052

Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter.

G Rudnick1, S S Steiner-Mordoch, H Fishkes, Y Stern-Bach, S Schuldiner.   

Abstract

The energetics of reserpine binding to the bovine adrenal biogenic amine transporter suggest that H+ ion translocation converts the transporter to a form which binds reserpine essentially irreversibly. Reserpine binding to bovine adrenal chromaffin granule membrane vesicles is accelerated by generation of a transmembrane pH difference (delta pH) (interior acid) or electrical potential (delta psi) (interior positive). Both components of the electrochemical H+ potential (delta mu H+) must be dissipated to block reserpine binding, and generation of either one stimulates the binding rate. Reserpine binding is less dependent than amine transport on the delta pH, suggesting that translocation of fewer H+ ions is required to expose the high-affinity site than are required for net transport. Bound reserpine dissociates very slowly, if at all, from the transporter. Binding is stable to 1% cholate, 1.5% Triton X-100, 1 M SCN-, and 8 M urea, but sodium dodecyl sulfate (0.035%) and high temperatures (100 degrees C) released bound reserpine, indicating that binding is noncovalent. The results raise the possibility that the transporter, by translocating one H+ ion outward down its concentration gradient, is converted to a form that can either transport a neutral substrate molecule inward or occlude reserpine in a dead-end complex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140052     DOI: 10.1021/bi00455a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium.

Authors:  Y Stern-Bach; J N Keen; M Bejerano; S Steiner-Mordoch; M Wallach; J B Findlay; S Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

2.  A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE.

Authors:  T R Muth; S Schuldiner
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

3.  The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles.

Authors:  K Schwartz; A Weizman; M Rehavi
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

Review 4.  The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.

Authors:  K P Lesch; A Heils; P Riederer
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

Review 5.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

Review 6.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

7.  Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.

Authors:  Dana Yaffe; Ariela Vergara-Jaque; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

8.  Catecholamines up integrates dopamine synthesis and synaptic trafficking.

Authors:  Zhe Wang; Faiza Ferdousy; Hakeem Lawal; Zhinong Huang; J Gavin Daigle; Iyare Izevbaye; Olugbenga Doherty; Jerrad Thomas; Dean G Stathakis; Janis M O'Donnell
Journal:  J Neurochem       Date:  2011-11-03       Impact factor: 5.372

Review 9.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

10.  Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.

Authors:  Dana Yaffe; Sebastian Radestock; Yonatan Shuster; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.